Neurology Today editor-in-chief to deliver Taubman Institute's visiting professor lecture Sept. 6
Steven P. Ringel, M.D., editor-in-chief of Neurology Today, will deliver the Taubman Institute's Visiting Professor Lecture at noon on Sept. 6 in Ann Arbor.
Dr. Ringel is Professor of Neurology and Vice President for Clinical Effectiveness and Patient Safety at the University of Colorado Hospital (UCH). He has authored numerous articles and four books covering a broad range of issues in research, patient care, health policy,and patterns of practice. He is the founding editor of Current Treatment in Neurology and the current Editor-in-Chief of Neurology Today. He is past president of the American Academy of Neurology (AAN) and of the medical staff of UCH.
Dr. Ringel's current investigative activities emphasize quality and safety initiatives, cost effectiveness analysis and community database development. He has directed the Neuromuscular Section of the University of Colorado School of Medicine since 1976. He continues to have a busy neuromuscular practice and is actively involved in multi-university studies to evaluate drug efficacy in amyotrophic lateral sclerosis.
An honors graduate of the University of Michigan Medical School, Dr. Ringel completed his neurology residency at Rush-Presbyterian-St. Luke's Medical Center in Chicago and a post-doctoral research fellowship at the National Institutes of Health. He completed a Robert Wood Johnson Health Policy Fellowship and served as an Institute of Medicine Scholar-in-Residence working as Senator Jay Rockefeller's health policy aide during the 1992 Congressional session.
Dr. Ringel's lecture is entitled "Academic hospitals: the imperative for performance improvement," and is presented jointly with the Department of Internal Medicine's Grand Rounds program. The talk is scheduled for noon - 1 p.m. in the Ford Auditorium at the University of Michigan Hospital.
CME credit for physicians is available.
Stem cell symposium set for Sept. 19 in Ann Arbor
Dr. Eva Feldman will be among the speakers at the one-day event, which focuses on cutting-edge developments in stem-cell biology, epigenetics and regneratrive medicine.
Click here for details and registration.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.